These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17128974)

  • 21. Determination of the binding mode of thienopyrimidinedione antagonists to the human gonadotropin releasing hormone receptor using structure-activity relationships, site-directed mutagenesis, and homology modeling.
    Betz SF; Lio FM; Gao Y; Reinhart GJ; Guo Z; Mesleh MF; Zhu YF; Struthers RS
    J Med Chem; 2006 Oct; 49(21):6170-6. PubMed ID: 17034124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mapping the binding site of melanocortin 4 receptor agonists: a hydrophobic pocket formed by I3.28(125), I3.32(129), and I7.42(291) is critical for receptor activation.
    Hogan K; Peluso S; Gould S; Parsons I; Ryan D; Wu L; Visiers I
    J Med Chem; 2006 Feb; 49(3):911-22. PubMed ID: 16451057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspartic acid scaffold in bradykinin B1 antagonists.
    Huszár J; Timár Z; Bogár F; Penke B; Kiss R; Szalai KK; Schmidt E; Papp A; Keseru G
    J Pept Sci; 2009 Jun; 15(6):423-34. PubMed ID: 19378355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding of 2-aryl-4-(piperidin-1-yl)butanamines and 1,3,4-trisubstituted pyrrolidines to human CCR5: a molecular modeling-guided mutagenesis study of the binding pocket.
    Castonguay LA; Weng Y; Adolfsen W; Di Salvo J; Kilburn R; Caldwell CG; Daugherty BL; Finke PE; Hale JJ; Lynch CL; Mills SG; MacCoss M; Springer MS; DeMartino JA
    Biochemistry; 2003 Feb; 42(6):1544-50. PubMed ID: 12578367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling molecular mechanisms of binding of the anaphylatoxin C5a to the C5a receptor.
    Nikiforovich GV; Marshall GR; Baranski TJ
    Biochemistry; 2008 Mar; 47(10):3117-30. PubMed ID: 18275159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G; Bouthillier J; Marceau F
    Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping the binding site of six nonpeptide antagonists to the human V2-renal vasopressin receptor.
    Macion-Dazard R; Callahan N; Xu Z; Wu N; Thibonnier M; Shoham M
    J Pharmacol Exp Ther; 2006 Feb; 316(2):564-71. PubMed ID: 16234409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mapping of the laminin-binding site of the N-terminal agrin domain (NtA).
    Mascarenhas JB; Rüegg MA; Winzen U; Halfter W; Engel J; Stetefeld J
    EMBO J; 2003 Feb; 22(3):529-36. PubMed ID: 12554653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and biophysical analysis of two double-transmembrane domain-containing fragments from a yeast G protein-coupled receptor.
    Cohen LS; Arshava B; Estephan R; Englander J; Kim H; Hauser M; Zerbe O; Ceruso M; Becker JM; Naider F
    Biopolymers; 2008; 90(2):117-30. PubMed ID: 18260136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of dihydroquinoxalinone acetamides containing bicyclic amines as potent Bradykinin B1 receptor antagonists.
    Chen JJ; Qian W; Biswas K; Viswanadhan VN; Askew BC; Hitchcock S; Hungate RW; Arik L; Johnson E
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4477-81. PubMed ID: 18674903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the structure of the N-terminal domain from the Y4 receptor - a G protein-coupled receptor - and its interaction with hormones from the NPY family.
    Zou C; Kumaran S; Markovic S; Walser R; Zerbe O
    Chembiochem; 2008 Sep; 9(14):2276-84. PubMed ID: 18767100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. B1 bradykinin receptor homo-oligomers in receptor cell surface expression and signaling: effects of receptor fragments.
    Kang DS; Gustafsson C; Mörgelin M; Leeb-Lundberg LM
    Mol Pharmacol; 2005 Jan; 67(1):309-18. PubMed ID: 15492119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
    Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
    J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists.
    Meini S; Cucchi P; Bellucci F; Catalani C; Faiella A; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Biochem Pharmacol; 2004 Feb; 67(4):601-9. PubMed ID: 14757160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes.
    Boeckler F; Lanig H; Gmeiner P
    J Med Chem; 2005 Feb; 48(3):694-709. PubMed ID: 15689154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alanine screening of the intracellular loops of the human bradykinin B receptor--effects on receptor maintenance, G protein activation and internalization.
    Faussner A; Wennerberg G; Schüssler S; Feierler J; Seidl C; Jochum M; Proud D
    FEBS J; 2009 Jul; 276(13):3491-503. PubMed ID: 19456859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invariant chain transmembrane domain trimerization: a step in MHC class II assembly.
    Dixon AM; Stanley BJ; Matthews EE; Dawson JP; Engelman DM
    Biochemistry; 2006 Apr; 45(16):5228-34. PubMed ID: 16618111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alanine scanning mutagenesis of the second extracellular loop of type 1 corticotropin-releasing factor receptor revealed residues critical for peptide binding.
    Gkountelias K; Tselios T; Venihaki M; Deraos G; Lazaridis I; Rassouli O; Gravanis A; Liapakis G
    Mol Pharmacol; 2009 Apr; 75(4):793-800. PubMed ID: 19124613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystal structure of Thermus thermophilus tRNA m1A58 methyltransferase and biophysical characterization of its interaction with tRNA.
    Barraud P; Golinelli-Pimpaneau B; Atmanene C; Sanglier S; Van Dorsselaer A; Droogmans L; Dardel F; Tisné C
    J Mol Biol; 2008 Mar; 377(2):535-50. PubMed ID: 18262540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.